Microsoft's Copilot is getting even better at research thanks to a new feature that combines the power of both OpenAI's ChatGPT and Anthropic's Claude. In a blog post announcing Copilot Cowork's ...

Microsoft is using Anthropic’s Claude to review work by OpenAI’s GPT inside Copilot’s Researcher agent. (GeekWire Photo / Todd Bishop) A new feature from Microsoft uses Anthropic’s Claude to assess ...

OpenAI CEO Sam Altman is still in the hot seat this week after his company signed a deal with the US military. OpenAI employees have criticized the move, which came after Anthropic’s roughly $200 ...

Researchers at Stanford and Caltech have found some critical reasoning failures in advanced AI models. LLMs are great at recognizing patterns, but they have trouble with basic logic, social reasoning, ...

Different AI models win at images, coding, and research. App integrations often add costly AI subscription layers. Obsessing over model version matters less than workflow. The pace of change in the ...

Rising alert volumes, talent shortages, and tool sprawl have pushed security operations beyond a sustainable cost structure. Autonomous SOCs, powered by hyper automation, AI agents, and scalable ...

TL;DR: Tesla has placed its lane-centering Autosteer feature behind a $99/month Full Self-Driving (FSD) subscription, ending free Basic Autopilot after seven years. This move aims to boost FSD ...

It turns out that when the smartest AI models “think,” they might actually be hosting a heated internal debate. A fascinating new study co-authored by researchers at Google has thrown a wrench into ...

IRVINE, Calif. & LOS ANGELES, Calif. — January 13, 2026 — Turion Space Corp. (“Turion”), a space infrastructure company that builds and operates mission-grade spacecraft and space operations software, ...

SAN FRANCISCO--(BUSINESS WIRE)--Noetik, an AI-native biotech company pioneering self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, ...

Section 1. Purpose and Policy. Americans deserve access to the best medical treatments and research infrastructure in the world. In 2023, the Food and Drug Administration (FDA) completed a review of ...